Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115219
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2005-06-21
Brief Title:
Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly BIW in Rheumatoid Arthritis RA Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly QW
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-06-21
First Submit QC Date:
June 21 2005
Study First Post Date:
2005-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-28
Last Update Post Date:
2013-05-30
Last Update Post Date Type:
ESTIMATED